Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenomeQuest, a subsidiary of Aptean, is a leading provider of intellectual property (IP) sequence search solutions for the life sciences industry. Its flagship platform enables researchers to search for DNA, RNA, and protein sequences across the world's largest IP sequence database, GQ-Pat, which contains over 694 million sequences. The company's tools are used by top pharmaceutical, biotechnology, and agrochemical firms to conduct freedom-to-operate (FTO) analyses, patentability searches, and competitive intelligence. By integrating advanced search algorithms like BLAST and GenePAST with comprehensive patent data, GenomeQuest helps organizations protect their innovations and navigate the complex global patent landscape. The platform also offers specialized modules for antibody search and sequence variation discovery, streamlining the analysis of complex genomic data. GenomeQuest's solutions are trusted by major patent offices and law firms worldwide to ensure thorough and accurate IP discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenomeQuest.